TIBET TOURISM(600749)
Search documents
7月29日重要资讯一览
Zheng Quan Shi Bao Wang· 2025-07-29 13:15
Group 1 - The State-owned Assets Supervision and Administration Commission announced the establishment of China Chang'an Automobile Group Co., Ltd., which will be managed by the State Council [2] - The Hong Kong Monetary Authority released documents regarding the regulatory framework for stablecoin issuers, effective from August 1, 2025 [3] - The Ministry of Finance reported that from January to June 2025, state-owned enterprises had total operating revenue of 4,074.96 billion yuan, a year-on-year decrease of 0.2% [3] Group 2 - Zhejiang Province's Science and Technology Department proposed measures to enhance financial support for innovation, aiming for 80% of new listed companies in the technology sector by 2027 [4] - Companies such as Chang'an Automobile and Dong'an Power have undergone changes in their indirect controlling shareholders to China Chang'an Automobile [6] - Shijia Photon reported a net profit of 217 million yuan for the first half of the year, a year-on-year increase of 1712% [6]
七连板西藏旅游:未与雅鲁藏布江下游水电工程相关单位开展业务合作
Zhi Tong Cai Jing· 2025-07-29 10:38
西藏旅游(600749)(600749.SH)公告称,公司股票于2025年7月21日至7月29日连续七个交易日以涨停 价收盘,公司已连续五次披露股票交易异常波动公告和风险提示公告。 截至本公告披露日,公司未发现需要澄清的媒体报道或市场传闻,公司未与雅鲁藏布江下游水电工程相 关单位开展业务合作。 ...
七连板西藏旅游:公司未与雅下工程相关单位开展业务合作
Zheng Quan Shi Bao Wang· 2025-07-29 10:35
人民财讯7月29日电,七连板西藏旅游(600749)7月29日晚间披露股票交易风险提示公告称,鉴于近日 公司股价波动幅度较大,可能存在市场情绪过热、非理性炒作,以及短期上涨过快可能出现的下跌风 险,敬请广大投资者注意二级市场交易风险,审慎决策,理性投资。截至目前,公司未发现需要澄清的 媒体报道或市场传闻,公司未与雅鲁藏布江下游水电工程相关单位开展业务合作。 ...
七连板西藏旅游(600749.SH):未与雅鲁藏布江下游水电工程相关单位开展业务合作
智通财经网· 2025-07-29 10:34
截至本公告披露日,公司未发现需要澄清的媒体报道或市场传闻,公司未与雅鲁藏布江下游水电工程相 关单位开展业务合作。 智通财经APP讯,西藏旅游(600749.SH)公告称,公司股票于2025年7月21日至7月29日连续七个交易日 以涨停价收盘,公司已连续五次披露股票交易异常波动公告和风险提示公告。 ...
西藏旅游(600749) - 西藏旅游股票交易风险提示公告
2025-07-29 10:33
证券代码:600749 证券简称:西藏旅游 公告编号:2025-027 号 西藏旅游股份有限公司 股票交易风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 鉴于近日公司股价波动幅度较大,可能存在市场情绪过热、非理性炒作,以 及短期上涨过快可能出现的下跌风险,敬请广大投资者注意二级市场交易风险, 审慎决策,理性投资。 西藏旅游股份有限公司(以下简称"公司")股票于 2025 年 7 月 21 日至 7 月 29 日连续七个交易日以涨停价收盘,公司已连续五次披露股票交易异常波 动公告和风险提示公告。 鉴于近日公司股价波动幅度较大,可能存在市场情绪过热、非理性炒作, 以及短期上涨过快可能出现的下跌风险,敬请广大投资者审慎决策,理性投资。 一、公司生产经营情况未发生重大变化 截至本公告披露日,公司主营业务、生产经营情况以及经营环境与前期披露 的信息相比未发生重大变化,不存在应披露而未披露的信息。2023 年-2024 年, 公司营业收入分别为 21,304 万元、21,341 万元,归属于上市公司股东的净利润 分别为 1, ...
西藏旅游:公司已连续五次披露股票交易异常波动公告和风险提示公告
Xin Lang Cai Jing· 2025-07-29 10:21
西藏旅游公告,公司股票于2025年7月21日至7月29日连续七个交易日以涨停价收盘。公司已连续五次披 露股票交易异常波动公告和风险提示公告。7月29日公司股票交易换手率为1.76%。公司提醒广大投资 者注意二级市场交易风险,审慎决策,理性投资。 ...
强势股追踪 主力资金连续5日净流入49股
Zheng Quan Shi Bao Wang· 2025-07-29 08:53
| 688120 | 华海清 | 5 | 1.08 | 4.02 | 5.15 | | --- | --- | --- | --- | --- | --- | | | 科 | | | | | | 300203 | 聚光科 | 6 | 0.99 | 4.90 | 6.41 | | | 技 | | | | | | 688503 | 聚和材 | 5 | 0.98 | 5.57 | 9.57 | | | 料 | | | | | | 600730 | 中国高 | 5 | 0.95 | 7.96 | 16.52 | | | 科 | | | | | | 300870 | 欧陆通 | 5 | 0.90 | 3.85 | 3.84 | | 600038 | 中直股 | 5 | 0.85 | 4.87 | 1.76 | | | 份 | | | | | | 002637 | 赞宇科 | 5 | 0.84 | 5.61 | 7.78 | | | 技 | | | | | | | 申菱环 | | | | | | 301018 | 境 | 5 | 0.80 | 4.91 | 9.67 | | 000708 | 中信特 | 5 | 0.75 ...
旅游及景区板块7月29日涨0.27%,西藏旅游领涨,主力资金净流出2.85亿元
Zheng Xing Xing Ye Ri Bao· 2025-07-29 08:47
Group 1 - The tourism and scenic spots sector increased by 0.27% compared to the previous trading day, with Tibet Tourism leading the gains [1] - On the same day, the Shanghai Composite Index closed at 3609.71, up 0.33%, while the Shenzhen Component Index closed at 11289.41, up 0.64% [1] - Tibet Tourism's stock price rose by 10.00% to 23.31, with a trading volume of 39,900 lots and a transaction value of 92.95 million yuan [1] Group 2 - The main funds in the tourism and scenic spots sector experienced a net outflow of 285 million yuan, while retail investors saw a net inflow of 283 million yuan [3] - Speculative funds had a net inflow of 2.35 million yuan [3]
3600点上的医药狂欢,是机会还是陷阱?帮主三点说透
Sou Hu Cai Jing· 2025-07-29 07:51
Core Viewpoint - The market shows mixed signals with a strong performance in specific sectors like pharmaceuticals and technology, while many individual stocks are declining, indicating a concentrated investment strategy among funds [1][3]. Pharmaceuticals Sector - The pharmaceutical sector saw a surge with several companies hitting the daily limit, driven by a significant deal between Heng Rui Medicine and GlaxoSmithKline worth $12.5 billion, marking the largest overseas contract for a Chinese pharmaceutical company [3]. - Policy support is evident as the National Medical Insurance Administration has clarified that "innovative drugs will not be included in centralized procurement," which opens up profit margins for pharmaceutical companies [3]. - The outflow of capital into the sector is notable, with over 5 billion net inflow in three days, indicating strong institutional interest [3][4]. Technology Sector - The technology sector, particularly the PCB (Printed Circuit Board) segment, is gaining traction, with companies like Fangbang and Woge Optical hitting the daily limit, and Shenghong Technology seeing a 17% increase, reaching a market cap of over 150 billion [3]. - The demand for high-end PCBs is surging due to Nvidia resuming supply and an explosion in the need for 800G optical modules, with orders extending to 2026 [3]. - The unveiling of Huawei's Ascend 384 super node at the World Artificial Intelligence Conference has further fueled interest in related stocks [3]. Infrastructure and Regional Development - The Yajiang Hydropower Station concept stocks are experiencing renewed interest, with companies like Tibet Tianlu and Xining Special Steel hitting the daily limit, driven by a surge in equipment orders as the project enters a critical construction phase [5]. - The regional scarcity of infrastructure stocks in Tibet benefits from policy incentives, such as tax breaks under the "Western Development" initiative [5]. Market Dynamics and Strategy - The trading volume today was 1.83 trillion, slightly up from the previous day, but to break through the 3610-point resistance, it needs to exceed 1.9 trillion [6]. - The upcoming Federal Reserve meeting could influence foreign capital inflow, depending on signals regarding interest rate cuts [6]. - A strategy of maintaining a 50% position in "hard logic" stocks (pharmaceuticals, PCBs, and Yajiang-related stocks) while avoiding speculative and cyclical stocks is recommended [7][8].
西藏旅游7连板领涨,创新药概念股强势,全市场31只股票涨停
Jin Rong Jie· 2025-07-29 05:20
Group 1 - The market saw a total of 31 stocks hitting the daily limit up, with a success rate of 63% for limit up attempts [1] - Xizang Tourism became a market focus, achieving a consecutive limit up for 7 trading days, making it a representative high-limit stock [1] - Innovative drug concept stocks showed strong performance, with Apac Pharmaceutical achieving 5 limit ups in 10 trading days due to improved earnings expectations from a subsidiary sale [1] Group 2 - The overall market performance indicated a slight decline in the Shanghai Composite Index by 0.08% and Shenzhen Component Index by 0.04%, while the ChiNext Index rose by 0.92% [1] - The total trading volume in the three major markets reached 11,460.26 billion yuan, with 3,901 stocks declining and 1,468 stocks rising [1] - The chemical pharmaceutical sector attracted the highest net inflow of funds at 1.568 billion yuan, followed by the biopharmaceutical sector with 1.245 billion yuan [1] Group 3 - Other stocks that hit the limit up included Xingfu Blue Ocean, Kejingyuan, and Haichang New Materials, with some ChiNext stocks achieving a 20% limit up, indicating strong market enthusiasm for related concepts [2] - Medical research outsourcing institutions (CRO) and contract development manufacturing organizations (CDMO) were among the top-performing sectors, along with FPGA chips and CXO medical outsourcing [2]